PharMerica (PMC) Tops Q3 EPS by 16c; Guides In-Line
PharMerica Corporation (NYSE: PMC) reports Q3 EPS of $0.48, 16 cents better than the analyst estimate of $0.32. Revenue for the quarter was $461 million, which compares to the estimate of $461.38 million.
PharMerica sees FY EPS of $1.23-$1.32, versus the consensus of $1.28.
PharMerica sees FY EPS of $1.23-$1.32, versus the consensus of $1.28.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- ATA, Inc. (ATAI) Misses Q4 EPS by 1c; Guides FY13 Revs Below
- Toro Co. (TTC) Tops Q1 EPS by 13c; Guides FY12 EPS Above Views; to Split Stock
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
